An unexpected rebound amid news of intensified acquisition proposals and defense of support levels

Reviewing Prediction vs. Actual Result

At the time of entry, the projected return was expected to be 4.5%, but the actual realized return reached 13.8%, resulting in an OVERHIT designation. At that time, the current price of $3.92 was positioned above the 20-day low support line ($3.68), and a rebound attempt toward the resistance line ($4.30) was assumed despite an RSI (14) of 56.5 and non-aligned moving averages. When the M&A-related disclosure and news of Curaleaf's strengthened acquisition proposal coincided, the pattern from the prior history—where similar past events showed strong upward reactions of +31.3% and +12.2%—acted positively on the actual price movement this time as well, driving a much larger-than-expected surge.

What to Watch in the Next Analysis

Through this trade, we confirmed how explosive the synergy can be when the prior history pattern of a stock combined with positive news aligns with a rebound near the support line. In future trades, rather than simply looking at a predetermined take-profit target, we will implement a strategy of holding the position a bit more flexibly when momentum remains strong, taking into account the magnitude of volatility in past similar events.